Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Cryo-Cell and Monash University enter into autoimmune disease collaboration

Aug. 18, 2010

ValiRx to develop CRT's prostate cancer candidate VAL-201

Aug. 17, 2010

NextWave and Tris Pharma to collaborate on CNS drug development

Aug. 17, 2010

Alectos and Merck & Co. to codevelop O-GlcNAcase modulators for AD

Aug. 17, 2010

Humanetics receives licenses for medical radiation countermeasures

Aug. 16, 2010

Epitomics spins out new antibody therapeutics company, Apexigen

Aug. 16, 2010

TLV and Emergent BioSolutions to codevelop H5 influenza vaccine

Aug. 16, 2010

Allozyne partners with Sigma-Aldrich for cycloaddition chemistry

Aug. 16, 2010

PregLem inlicenses bentamapimod from Merck Serono for postoperative adhesions and endometriosis

Aug. 13, 2010

NeoStem and Schepens Eye Research Institute enter agreement for retinal diseases

Aug. 13, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...